Results 191 to 200 of about 484,484 (318)

Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Paltusotine is a novel, nonpeptide, selective somatostatin receptor 2 agonist in development for the treatment of acromegaly and carcinoid syndrome. This study investigated the mass balance, routes of excretion, absolute bioavailability and metabolite profile of orally administered paltusotine.
Rosa Luo, Ajay Madan, Christine T. Ferrara‐Cook, Deepak Dalvie, Lance Goulet, R. Scott Struthers, Alan S. Krasner   +6 more
wiley   +1 more source

Recent advances of nanomaterials in imaging liver fibrosis

BMEMat, EarlyView.
Schematic summary on the latest strategies of liver fibrosis imaging based on various nanomaterials. Abstract Liver fibrosis is a pathological process resulting from prolonged exposure to various injury factors. It is characterized by the abnormal proliferation and activation of hepatic stellate cells and excessive deposition of extracellular matrix ...
Jin Cui, Shuxuan Zhang, Xueli Xu, Ke Ren, Mengzhen Dong, Zhaokun Nie, Yang Xu, Xiaohui Dai, Peng Xu, Shuo Sun, Xinya Zhao, Xiao Sun   +11 more
wiley   +1 more source

Chronic active and chronic inactive hepatitis B virus infection: Comparative study of genetic polymorphism and blood profile measures. [PDF]

PLoS One
Awadelkarim KE, Osman NAM, Eleragi AMS, Nail AMA, Abuzeid N, Elangeeb ME, Ahmed EM, Al-Faifi JA, Alhalafi A, Doghish AS, Mohammed OA.   +10 more
europepmc   +1 more source

Liver organoids: From 3D printing to biomedical applications

BMEMat, EarlyView.
A comprehensive review on liver organoids culture techniques from 3D printing to organ‐on‐chip, as well as focusing on challenges and perspectives for advancement liver organoids in various future applications. Abstract The liver is an immune organ, especially an immune tolerance organ.
Ying Shi, Xin Han, Zheng Zhang, Jiangtao Xu, Guozhen Liu   +4 more
wiley   +1 more source

Effectiveness of catch-up vaccination from 2009 to 2011 on incidence of hepatitis B in Guangzhou, China: a time series analysis. [PDF]

BMC Public Health
Ming BW, Liu WH, Li L, Zhang JL, Liu J, Ma JJ, Huang HN, Zhang ZB, Ou CQ.   +8 more
europepmc   +1 more source

Hepatitis E vaccination: the promise of prevention. [PDF]

Proc (Bayl Univ Med Cent)
Gonzalez SA.
europepmc   +1 more source

Pareto in Prison

Behavioral Sciences &the Law, EarlyView.
ABSTRACT The Pareto principle is based on the concept that roughly 80% of outcomes are generated by 20% of inputs, efforts, or contributors within a group. Using a national sample of U.S. prison inmates, we examined various percentile rankings of self‐reported institutional misconduct to determine how much disorder is created behind bars by the most ...
Mark A. Morgan, Joshua S. Long, Matthew W. Logan, Frank Benton   +3 more
wiley   +1 more source

Hepatitis B associated with severe COVID-19: a nationwide cohort study in Sweden. [PDF]

Virol J
Jakobsson F, Fonseca-Rodríguez O, Jerndal H, Kalucza S, Aleman S, Eriksson M, Fors Connolly AM.   +6 more
europepmc   +1 more source

Towards the elimination of Viral Hepatitis in Clinton County, New York [PDF]

Chronic viral hepatitis is a major public health issue, affecting approximately 300 million persons globally. In Clinton County, New York, chronic viral hepatitis remains a major concern, with incidence rates for hepatitis C virus infection (HCV) in the ...
Le, Michael H.
core   +1 more source

Chronic Hepatitis: A Review [PDF]

Journal of the Royal Society of Medicine, 1985
openaire   +4 more sources